Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance NASDAQ:SRNE opened at $0.00 on Monday. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance NASDAQ:SRNE opened at $0.00 on Monday. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of […]
